ProfileGDS4718 / 208792_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 82% 88% 98% 75% 85% 69% 57% 82% 93% 88% 81% 98% 49% 66% 63% 93% 90% 61% 65% 65% 88% 88% 80% 88% 85% 68% 90% 64% 78% 57% 65% 94% 85% 68% 75% 79% 63% 93% 92% 99% 88% 66% 87% 64% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.1416882
GSM549102patient 115, normal, homogenized [OPG study]8.808188
GSM549104patient 119, normal, homogenized [OPG study]11.493398
GSM549108patient 138, normal, homogenized [OPG study]7.219675
GSM549119patient 077, normal, homogenized [OPG study]8.4000885
GSM549133patient 032, cancer, homogenized [OPG study]6.8321169
GSM549139patient 042, cancer, homogenized [OPG study]5.9361557
GSM549099patient 107, normal, homogenized [OPG study]7.9702282
GSM549109patient 139, normal, homogenized [OPG study]9.7627793
GSM549110patient 046, normal, homogenized [OPG study]8.8597888
GSM549114patient 063, normal, homogenized [OPG study]8.0501281
GSM549122patient 082, normal, homogenized [OPG study]11.308798
GSM549134patient 033, cancer, homogenized [OPG study]5.4639749
GSM549136patient 036, cancer, homogenized [OPG study]6.5300866
GSM549140patient 044, cancer, homogenized [OPG study]6.2940163
GSM549111patient 047, normal, homogenized [OPG study]9.8967793
GSM549113patient 057, normal, homogenized [OPG study]9.4510790
GSM549132patient 031, cancer, homogenized [OPG study]6.1955561
GSM549137patient 038, cancer, homogenized [OPG study]6.4850465
GSM549142patient 047, cancer, homogenized [OPG study]6.5494265
GSM549100patient 110, normal, homogenized [OPG study]8.8479688
GSM549107patient 135, normal, homogenized [OPG study]8.8944388
GSM549115patient 068, normal, homogenized [OPG study]7.908780
GSM549116patient 072, normal, homogenized [OPG study]9.0097788
GSM549120patient 078, normal, homogenized [OPG study]8.5288585
GSM549131patient 030, cancer, homogenized [OPG study]6.7239368
GSM549118patient 074, normal, homogenized [OPG study]9.2219290
GSM549129patient 027, cancer, homogenized [OPG study]6.4428664
GSM549123patient 088, normal, homogenized [OPG study]7.6610478
GSM549124patient 006, cancer, homogenized [OPG study]5.9618357
GSM549126patient 015, cancer, homogenized [OPG study]6.4888965
GSM549128patient 025, cancer, homogenized [OPG study]10.02194
GSM549103patient 117, normal, homogenized [OPG study]8.3824585
GSM549117patient 073, normal, homogenized [OPG study]6.6776268
GSM549138patient 041, cancer, homogenized [OPG study]7.4196875
GSM549141patient 045, cancer, homogenized [OPG study]7.8646879
GSM549130patient 028, cancer, homogenized [OPG study]6.3005163
GSM549101patient 111, normal, homogenized [OPG study]9.7124593
GSM549105patient 128, normal, homogenized [OPG study]9.6232492
GSM549106patient 134, normal, homogenized [OPG study]11.993799
GSM549112patient 048, normal, homogenized [OPG study]8.9363188
GSM549125patient 011, cancer, homogenized [OPG study]6.530666
GSM549127patient 024, cancer, homogenized [OPG study]8.7251887
GSM549135patient 035, cancer, homogenized [OPG study]6.4313964